This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See SmPC, section 4.8 for how to report adverse reactions.
Copyright © 2017-2023. Website content is subject to copyright protection.
Please refer to Terms of Use for more information.
You are now pre-registered for PYLCLARI™ training. We have received your details and are currently processing your request. Once this is completed, Curium will contact you with instructions on how to access the content.